Number of Insiders Selling: 11 First among the 10 stocks insiders are selling this month is the biopharmaceutical company Blueprint Medicines Corporation (NASDAQ:BPMC). The Cambridge, ...

Blueprint Medicines' strong pipeline and Ayvakit growth make it promising. Read why BPMC stock is rated "Hold" due to high ...

That control is starting to fray as Mr. Johnson, a longevity guru known for performing experiments on his body, faces a ...

Blueprint Medicines Corporation focuses on Ayvakit, BLU-808, and Elenestinib with strong potential in mast cell disorders.

As a boots-on-the-ground project engineer and superintendent, Taylor Boileau has seen both the good and the bad sides of ...

Climate-related weather events have had a $2 trillion impact on the global economy over the last decade, the company said. The new Omniverse Blueprint equips users with the latest technologies to ...

Corebridge Financial Inc. trimmed its position in Blueprint Medicines Co. (NASDAQ:BPMC – Free Report) by 6.0% during the 4th quarter, HoldingsChannel.com reports. The firm owned 31,613 shares of the ...

Learn more about whether Blueprint Medicines Corporation or Moderna, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

McLean & Company's latest research ... while supporting meaningful coaching and continuous development. The blueprint makes a compelling case: organizations that embed human-centric practices ...